These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10484859)

  • 1. Differences in the ratios of morphine to methadone in patients with neuropathic pain versus non-neuropathic pain.
    Gagnon B; Bruera E
    J Pain Symptom Manage; 1999 Aug; 18(2):120-5. PubMed ID: 10484859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine.
    Bruera E; Pereira J; Watanabe S; Belzile M; Kuehn N; Hanson J
    Cancer; 1996 Aug; 78(4):852-7. PubMed ID: 8756381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotating to oral methadone in advanced cancer patients: a case series.
    Kilonzo I; Twomey F
    J Palliat Med; 2013 Sep; 16(9):1154-7. PubMed ID: 23631611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous methadone for cancer pain unrelieved by morphine and hydromorphone: clinical observations.
    Manfredi PL; Borsook D; Chandler SW; Payne R
    Pain; 1997 Mar; 70(1):99-101. PubMed ID: 9106815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study.
    Lawlor P; Turner K; Hanson J; Bruera E
    Pain; 1997 Aug; 72(1-2):79-85. PubMed ID: 9272790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine to methadone conversion: an interpretation of published data.
    Pollock AB; Tegeler ML; Morgan V; Baumrucker SJ
    Am J Hosp Palliat Care; 2011 Mar; 28(2):135-40. PubMed ID: 20555039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of chronic neuropathic pain with methadone: a review of 13 cases.
    Altier N; Dion D; Boulanger A; Choinière M
    Clin J Pain; 2005; 21(4):364-9. PubMed ID: 15951657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences.
    Ripamonti C; De Conno F; Groff L; Belzile M; Pereira J; Hanson J; Bruera E
    Ann Oncol; 1998 Jan; 9(1):79-83. PubMed ID: 9541687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of methadone in opioid rotation-a Polish experience.
    Leppert W
    Support Care Cancer; 2009 May; 17(5):607-12. PubMed ID: 19043743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid switch to oral methadone in cancer pain.
    Mancini I; Lossignol DA; Body JJ
    Curr Opin Oncol; 2000 Jul; 12(4):308-13. PubMed ID: 10888415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose ratios between high dose oral morphine or equivalents and oral methadone.
    Chatham MS; Dodds Ashley ES; Svengsouk JS; Juba KM
    J Palliat Med; 2013 Aug; 16(8):947-50. PubMed ID: 23662952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methadone rotation for cancer pain: an observational study.
    Tan C; Wong JF; Yee CM; Hum A
    BMJ Support Palliat Care; 2022 Dec; 12(e6):e736-e739. PubMed ID: 32321728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperative N-methyl-D-aspartate (NMDA) receptor antagonism and mu-opioid receptor agonism mediate the methadone inhibition of the spinal neuron pain-related hyperactivity in a rat model of neuropathic pain.
    Sotgiu ML; Valente M; Storchi R; Caramenti G; Biella GE
    Pharmacol Res; 2009 Oct; 60(4):284-90. PubMed ID: 19717013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone: an effective alternative to morphine for pain relief in cancer patients.
    Shelton BW; Deynes-Romero J; Tofani-Montalvo M; Ramírez-Rivera J; Jaumne-Anselmi F
    Bol Asoc Med P R; 2008; 100(3):7-10. PubMed ID: 19227708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine, oxycodone, methadone and its enantiomers in different models of nociception in the rat.
    Lemberg K; Kontinen VK; Viljakka K; Kylänlahti I; Yli-Kauhaluoma J; Kalso E
    Anesth Analg; 2006 Jun; 102(6):1768-74. PubMed ID: 16717324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study.
    Lawlor PG; Turner KS; Hanson J; Bruera ED
    Cancer; 1998 Mar; 82(6):1167-73. PubMed ID: 9506365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New Opioid Options in Japan - Methadone, Tapentadol and Hydromorphone].
    Takagi Y; Aruga E
    Gan To Kagaku Ryoho; 2018 Feb; 45(2):205-211. PubMed ID: 29483406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone for cancer pain.
    Nicholson AB
    Cochrane Database Syst Rev; 2004; (2):CD003971. PubMed ID: 15106230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?
    Ripamonti C; Groff L; Brunelli C; Polastri D; Stavrakis A; De Conno F
    J Clin Oncol; 1998 Oct; 16(10):3216-21. PubMed ID: 9779694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.